Advertisement

Topics

DexCom, Inc. Reports Fourth Quarter and Fiscal Year 2016 Financial Results

16:01 EST 28 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2016. Fourth Quarter and Full Year 2016 highlights: Total revenue grew to ...

Other Sources for this Article

DexCom, Inc.
Steven R. Pacelli
Executive Vice President, Strategy and Corporate Development
(858) 200-0200
www.dexcom.com

NEXT ARTICLE

More From BioPortfolio on "DexCom, Inc. Reports Fourth Quarter and Fiscal Year 2016 Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...